ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,039.32
      0.71%
      US Tech 100
      20,986.00
      0.56%
      Dow Jones
      43,927.57
      1.01%
      Brent Oil
      78.795
      -0.54%
      Bitcoin
      107,074.12
      4.94%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Sartorius Stedim Biotech SA (DIM) Quote

      Sartorius Stedim Biotech SA

      Sartorius Stedim Biotech SA (DIM)

      WisdomTree International MidCap Dividend Fund
      203.90
      3.50
      (1.75%)
      Closed January 21 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      203.90
      Bid
      202.50
      Ask
      205.50
      Volume
      47,923
      199.80 Day's Range 205.30
      139.10 52 Week Range 281.00
      Market Cap
      19.846B
      Previous Close
      200.40
      Open
      200.00
      Last Trade
      1
      @
      203.9
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      56,139
      Shares Outstanding
      97,330,405
      Dividend Yield
      0.34%
      PE Ratio
      64.08
      Earnings Per Share (EPS)
      3.18
      Revenue
      2.78B
      Net Profit
      309.7M

      About Sartorius Stedim Biotech SA

      Sector
      Lab Analytical Instruments
      Industry
      Lab Analytical Instruments
      Website
      www.sartorius.com
      Headquarters
      Marseille, Bouches-du-rhone, Fra
      Founded
      -
      Sartorius Stedim Biotech SA is listed in the Lab Analytical Instruments sector of the Euronext with ticker DIM. The last closing price for Sartorius Stedim Biotech was 200.40 €. Over the last year, Sartorius Stedim Biotech shares have traded in a share price range of 139.10 € to 281.00 €.

      Sartorius Stedim Biotech currently has 97,330,405 shares outstanding. The market capitalization of Sartorius Stedim Biotech is 19.51 € billion. Sartorius Stedim Biotech has a price to earnings ratio (PE ratio) of 64.08.

      Ask ADVFN Intelligence (AI)

      DIM Latest News

      More News

      FeaturedLuke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program

      4 hours ago

      Sartorius's Shares Drop on Outlook Cut, Preliminary 3Q Declines

      n By Andrea Figueras Shares in Sartorius tumbled Friday after the company downgraded its full-year targets and posted lower preliminary sales and earnings for the first nine months of 2023. At...

      October 13 2023
      Dow Jones News

      Sartorius, Sartorius Stedim Shares Fall After Polyplus Acquisition

      By Cecilia Butini Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA fell in opening trade on Friday after...

      March 31 2023
      Dow Jones News

      Sartorius Inks $2.6 Billion Deal for French Gene-Therapy Tech Firm Polyplus

      By Joshua Kirby Sartorius AG said Friday that it has reached a deal to buy French gene-therapy technology company Polyplus from a group of private investors for around 2.4 billion euros ($2.62...

      March 31 2023
      Dow Jones News

      Neuf premiers mois 2019 : Sartorius Stedim Biotech enregistre une croissance à deux chiffres de son chiffre d’affaires

      Chiffre d’affaires de 1 076,7 millions d’euros (+18,1 %) ; prises de commandes de 1 147,1 millions d’euros (+ 18,0 %) ; marge d’EBITDA courant de 29,0 % Forte croissance dans toutes les...

      October 21 2019
      Business Wire

      Sartorius Stedim Biotech off to a Dynamic Start in Fiscal 2019

      Sales revenue up 19.3%; order intake up 18.7%; earnings margin 28.6%1) Growth across all product categories and geographies; the Americas particularly strong Guidance for 2019...

      April 18 2019
      Business Wire

      Resolutions of the Annual Combined Shareholders' Meeting of Sartorius Stedim Biotech S.A.

      Regulatory News: At yesterday´s Annual General Shareholders' Meeting (AGM) of Sartorius Stedim Biotech S.A. (Paris:DIM) in Aubagne, France, shareholders passed the resolution to pay a...

      March 27 2019
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-2.6-1.25907990315206.5209.419464418199.80860427DE
      418.459.94877325425185.45209.4179.748843196.3998335DE
      1212.656.61437908497191.25209.4163.156139185.78020278DE
      2657.939.6575342466146214.8143.4565915181.8947186DE
      52-19.1-8.56502242152223281139.175212196.23631445DE
      156-174-46.0439269648377.9400.2139.160737248.52619235DE
      26041.925.8641975309162551133.961161271.89403234DE

      DIM - Frequently Asked Questions (FAQ)

      What is the current Sartorius Stedim Biotech share price?
      The current share price of Sartorius Stedim Biotech is 203.90 €
      How many Sartorius Stedim Biotech shares are in issue?
      Sartorius Stedim Biotech has 97,330,405 shares in issue
      What is the market cap of Sartorius Stedim Biotech?
      The market capitalisation of Sartorius Stedim Biotech is EUR 19.51B
      What is the 1 year trading range for Sartorius Stedim Biotech share price?
      Sartorius Stedim Biotech has traded in the range of 139.10 € to 281.00 € during the past year
      What is the PE ratio of Sartorius Stedim Biotech?
      The price to earnings ratio of Sartorius Stedim Biotech is 64.08
      What is the cash to sales ratio of Sartorius Stedim Biotech?
      The cash to sales ratio of Sartorius Stedim Biotech is 7.15
      What is the reporting currency for Sartorius Stedim Biotech?
      Sartorius Stedim Biotech reports financial results in EUR
      What is the latest annual turnover for Sartorius Stedim Biotech?
      The latest annual turnover of Sartorius Stedim Biotech is EUR 2.78B
      What is the latest annual profit for Sartorius Stedim Biotech?
      The latest annual profit of Sartorius Stedim Biotech is EUR 309.7M
      What is the registered address of Sartorius Stedim Biotech?
      The registered address for Sartorius Stedim Biotech is ZONE INDUSTRIELLE LES PALUDS AVENUE DE JOUQUES, BP 91051, MARSEILLE, BOUCHES-DU-RHONE, 13781
      What is the Sartorius Stedim Biotech website address?
      The website address for Sartorius Stedim Biotech is www.sartorius.com
      Which industry sector does Sartorius Stedim Biotech operate in?
      Sartorius Stedim Biotech operates in the LAB ANALYTICAL INSTRUMENTS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DMSBSDiagnostic Medical Systems
      0.007 €
      (75.00%)
      		36.27k
      POXELPoxel
      0.3905 €
      (60.04%)
      		6.13M
      GTRDSGroupe Tera DS
      0.12 €
      (43.71%)
      		32.95k
      MCPGrupo Media Capital Sgps Sa
      2.00 €
      (23.46%)
      		5
      ALDOLDolfines
      4.12 €
      (21.00%)
      		82.74k
      DRVDSDrone Volt DS
      0.0009 €
      (-50.00%)
      		707.14k
      HYPDSHipay Group DS
      0.011 €
      (-45.00%)
      		32.76k
      NICBSNicox SA
      0.0178 €
      (-22.61%)
      		11
      ALGENGenoway S A Inh Eo 15
      3.06 €
      (-19.69%)
      		123.45k
      ALBOOBOOSTHEAT
      0.058 €
      (-16.91%)
      		161k
      ATOAtos SE
      0.0022 €
      (10.00%)
      		3.39B
      BCPBanco Comercial Portugues SA
      0.5124 €
      (1.03%)
      		79.14M
      ALCYBCybergun
      0.0001 €
      (0.00%)
      		31.06M
      ALVERVergnet
      0.0014 €
      (-6.67%)
      		21.7M
      EDPEDP SA
      3.069 €
      (-1.76%)
      		12.59M

      Discussion

      View Full Feed
      Golden Cross Golden Cross 3 minutes ago
      $ADTX Loading here for possible pop tomorrow...

      #bottom #bottombounce #StocksInFocus
      ADTX
      jimr1717 jimr1717 3 minutes ago
      No doubt. The CONdog96 🤡™ clown Fools no one.
      ATMH
      HGilS HGilS 3 minutes ago
      Based on the number of posts, IB_ is not happy - he predicted we go down this week and only next week we start going up...
      ELTP
      threewheeler threewheeler 3 minutes ago
      yeap not even 2 milly volume, and more news anytime, leave inpatient sellers behind shortly FDCT
      FDCT
      jcromeenes jcromeenes 4 minutes ago
      Was total sarcasm.
      FNMA
      Viking61 Viking61 4 minutes ago
      Mmm, maybe $30 million after taxes😂
      FNMA
      CaptBeer CaptBeer 4 minutes ago
      Hello my Friends. The UK Script Numbers are in for November 2024. Use the link below to view and/or download my Summary Report:

      Slide # 1: Monthly comparison of VAZKEPA® vs. 3 Comparator Products from Jan 2022 to Nov. 2024
      Slide # 2: Same as Slide # 1 except only comparing VAZK
      AMRN
      mrfence mrfence 4 minutes ago
      Recent Instagram coverage of our FHFA pick, Bill Pulte.
      https://www.instagram.com/kennybsimpson/reel/DFDa4Qju-Pw/
      $FMCC~ $FNMA~
      FMCC FNMA
      yielddude yielddude 4 minutes ago
      AATC out at 9.08
      H2004 H2004 5 minutes ago
      Care to add $QMMM, a previous call-out of yours, to the list?
      QMMM
      StayHumble StayHumble 5 minutes ago
      wow💹25M+ $HIRU XPERT💹BUYS💹💹💹 https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades
      HIRU
      lifeonthefarm lifeonthefarm 5 minutes ago
      was a scam the minute 1.2b shares were freed up by insiders
      IGPK
      Bmrboy Bmrboy 5 minutes ago
      Seller being gone is good news. I said from the beginning that I'm not selling a single share under $3 on this one.
      Brooge warrants cancelled Brooge warrants cancelled 6 minutes ago
      you're up over a million, how much money do you need?
      FNMA
      Rainer Rainer 6 minutes ago
      https://x.com/PDGOInc/status/1881755140996444417
      PDGO
      MrJones77 MrJones77 6 minutes ago
      https://corpgov.law.harvard.edu/2024/11/06/chancery-rejects-bid-for-an-equitable-eraser/
      i_like_bb_stock i_like_bb_stock 6 minutes ago
      GWAV took a few down here had an offering last week, looks ready to bounce
      GWAV
      lifeonthefarm lifeonthefarm 6 minutes ago
      10 cents
      ADHC
      LVerstee LVerstee 6 minutes ago
      You are partially correct about one thing: I am retired, which means I have time. However, that time is dedicated to business. I made time specifically to help pursue justice for those who genuinely sought my help and needed it. A soft approach proved ineffective. Being labeled a criminal simply for
      ITUP
      i_like_bb_stock i_like_bb_stock 6 minutes ago
      GWAV took a few down here had an offering last week, looks ready to bounce
      GWAV
      GVInvestments GVInvestments 6 minutes ago
      Well I think when Lamberth saw videos of a person hitting the doors or windows of the capital and saw that person push and assault police officers he had no choice but to sentence that person. I think he will also see that harm and attack was done on Fannie Mae and that he needs to do justice and fr
      FNMA
      Chartmaster Chartmaster 6 minutes ago
      Target 158
      MMM
      IceCold8 IceCold8 6 minutes ago
      Well I wish I could buy like you. I haven't been able to work since 2022 and thought I'd at least have some pocket money.
      CGAC
      sab63090 sab63090 7 minutes ago
      Investor
      Hard to argue with those highlighted facts!

      Seems as though Missling stepped into some mud along this journey as you have suggested. Maybe Dr. Jin and Dr. Sabbagh have improved his position?

      You might have noticed that Dr. Talavera is a SVP which se
      AVXL

      Your Recent History

      EU
      DIM
      Sartorius Stedim Biotech
      TG
      DWLD
      Franklin Templeton ICAV
      LSE
      54OU
      Ladbroke 23
      LSE
      92IP
      Marston's 6%pf
      AMEX
      EZJ
      ProShares Ultra MSCI Japan
      BIBX
      MANAETH
      Decentraland
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads